Population structure, virulence factors and resistance determinants of invasive, non-invasive and colonizing Streptococcus agalactiae in Poland

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 9, 2010, Pages 1907-1914

  Sadowy, Ewa ^a   Matynia, Bozena ^a   Hryniewicz, Waleria ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

Alp; Erythromycin; MLST; Serotypes; Transposons

Indexed keywords

ERYTHROMYCIN; KETOLIDE; MACROLIDE; PROTEIN C; TETRACYCLINE; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; GENE SEQUENCE; GENETIC VARIABILITY; GROUP B STREPTOCOCCAL INFECTION; NONHUMAN; POLAND; POLYMERASE CHAIN REACTION; POPULATION STRUCTURE; SEROTYPE; SEROTYPING; STREPTOCOCCUS AGALACTIAE; TRANSPOSON;

EID: 77955596711     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq230     Document Type: Article

References (58)

1. Baker CJ. Group B streptococcal infections. In: Stevens DL, Kaplan EL, eds. Streptococcal Infections: Clinical Aspects, Microbiology and Molecular Pathogenesis. New York: Oxford University Press, 2000; 222-37.
2. Borchardt SM, DeBusscher JH, Tallman PA et al. Frequency of antimicrobial resistance among invasive and colonizing group B streptococcal isolates. BMC Infect Dis 2006; 6: 57.
3. De Mouy D, Cavallo JD, Leclercq R et al. Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study. Antimicrob Agents Chemother 2001; 45: 2400-2.
4. Figueira-Coelho J, Ramirez M, Salgado MJ et al. Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolideresistant isolates. Microb Drug Resist 2004; 10: 31-6.
5. Fluegge K, Supper S, Siedler A et al. Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany. Antimicrob Agents Chemother 2004; 48: 4444-6.
6. Gonzales JJ, Andreu A, the Spanish Group for the Study of Perinatal Infection from the Spanish Society for Clinical Microbiology and Infectious Diseases. Multicenter study of the mechanisms of resistance and clonal relationships of Streptococcus agalactiae isolates resistant to macrolides, lincosamides, and ketolides in Spain. Antimicrob Agents Chemother 2005; 49: 2525-7.
7. Jones N, Bohnsack JF, Takahashi S et al. Multilocus sequence typing system for group B streptococcus. J Clin Microbiol 2003; 41: 2530-6.
8. Slotved HC, Kong F, Lambertsen L et al. Serotype IX, a proposed new Streptococcus agalactiae serotype. J Clin Microbiol 2007; 45: 2929-36.
9. Gilbert GL. Vaccines for other neonatal infections: are group B streptococcal infections vaccine-preventable? Expert Rev Vaccines 2004; 3: 371-4.
10. Creti R, Fabretti F, Orefici G et al. Multiplex PCR assay for direct identification of group B streptococcal α-protein-like protein genes. J Clin Microbiol 2004; 42: 1326-9.
11. Lindahl G, Stalhammar-Carlemalm M, Areschoug T. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev 2005; 18: 102-27.
12. Hryniewicz W, Grzesiowski P, Ozorowski T. Hospital infection control in Poland. J Hosp Infect 2001; 49: 94-8.
13. Feil EJ, Li BC, Aanensen DM et al. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 2004; 186: 1518-30.
14. Bisharat N, Jones N, Marchaim D et al. Population structure of group B streptococcus from a low-incidence region for invasive neonatal disease. Microbiology 2005; 151: 1875-81.
15. Grundman H, Hori S, Tanner G. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol 2001; 39: 4190-2.
16. Kong F, Gowan S, Martin D et al. Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes. J Clin Microbiol 2002; 40: 620-6.
17. Maeland JA, Brakstad OG, Bevanger L et al. Streptococcus agalactiae β gene and gene product variations. J Med Microbiol 1997; 46: 999-1005.
18. Manning SD, Lacher DW, Davies HD et al. DNA polymorphism and molecular subtyping of the capsular gene cluster of group B streptococcus. J Clin Microbiol 2005; 43: 6113-6.
19. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
20. Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué 2005. Edition de Janvier 2005. Paris, France: Société Française de Microbiologie. http://www.sfm.asso.fr/publi/general.php?pa=5 (11 June 2010, date last accessed).
21. Kataja J, Huovinen P, Skurnik M et al. Erythromycin resistance genes in group A streptococci in Finland. Antimicrob Agents Chemother 1999; 43: 48-52.
22. Sutcliffe J, Grebe T, Tait-Kamradt A et al. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996; 40: 2562-6.
23. Okitsu N, Kaieda S, Yano H et al. Characterization of ermB transposition by Tn1545 and Tn917 in macrolide-resistant Streptococcus pneumoniae isolates. J Clin Microbiol 2005; 43: 168-73.
24. Cochetti I, Tili E, Vecchi M et al. New Tn916-related elements causing erm(B)-mediated erythromycin resistance in tetracycline-susceptible pneumococci. J Antimicrob Chemother 2007; 60: 127-31.
25. Cochetti I, Tili E, Mingoia M et al. erm(B) carrying elements in tetracycline-resistant pneumococci and correspondence between Tn1545 and Tn6003. Antimicrob Agents Chemother 2008; 52: 1285-90.
26. Varaldo PE, Montanari MP, Giovanetti E. Genetic elements responsible for erythromycin resistance in streptococci. Antimicrob Agents Chemother 2009; 53: 343-53.
27. Doherty N, Trzcinski K, Pickerill P et al. Genetic diversity of the tet(M) gene in tetracycline-resistant clonal lineages of Streptococcus pneumoniae. Antimicrob Agents Chemother 2000; 44: 2979-84.
28. Amezaga MR, Carter PE, Cash P et al. Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites. J Clin Microbiol 2002; 40: 3313-8.
29. Henderson-Begg SK, Roberts AP, Hall LMC. Diversity of putative Tn5253-like elements in Streptococcus pneumoniae. Int J Antimicrob Agents 2009; 33: 364-7.
30. Shaw JH, Clewell DB. Complete nucleotide sequence of macrolide-lincosamide-streptogramin B-resistance transposon Tn917 in Streptococcus faecalis. J Bacteriol 1985; 164: 782-96.
31. Agersø Y, Pedersen AG, Aarestrup FM. Identification of Tn5397-like and Tn916-like transposons and diversity of the tetracycline resistance gene tet(M) in eneterococci from humans, pigs and poultry. J Antimicrob Chemother 2006; 57: 832-9.
32. Trzciński K, Cooper BS, Hryniewicz W et al. Expression of resistance to tetracycline in strains of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2000; 45: 763-70.
33. Aminov RI, Garrigues-Jeanjean N, Mackie RI. Molecular ecology of tetracycline resistance: development and validation of primers for detection of tetracycline resistance genes encoding ribosomal protection proteins. Appl Environ Microbiol 2001; 67: 22-32.
34. Didelot X, Falush D. Inference of bacterial microevolution using multilocus sequence data. Genetics 175: 1251-66.
35. Huson DH, Bryant D. Application of phylogenetic networks in evolutionary studies, molecular biology and evolution. Mol Biol Evol 2006; 23: 254-67.
36. Brenciani A, Bacciaglia A, Vecchi M et al. Genetic elements carrying erm(B) in treptococcus pyogenes, and association with tet(M) tetracycline resistance gene. Antimicrob Agents Chemother 2007; 51: 1209-16.
37. Brochet M, Couve E, Zouine M et al. Genomic diversity and evolution within the species Streptococcus agalactiae. Microbes Infect 2006; 8: 1227-43.
38. Blumberg HM, Stephens DS, Modansky M et al. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis 1996; 173: 365-73.
39. Luan SL, Granlund M, Sellin M et al. Multilocus sequence typing of Swedish invasive group B Streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J Clin Microbiol 2005; 43: 3727-33.
40. Weisner AM, Johnson AP, Lamagni TL et al. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis 2004; 38: 1203-8.
41. Davies HD, Jones N, Whittam TS et al. Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. J Infect Dis 2004; 189: 1097-102.
42. Martins ER, Pessanha MA, Ramirez M et al. Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness. J Clin Microbiol 2007; 45: 3224-9.
43. Manning SD, Springman AC, Lehotzky E et al. Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J Clin Microbiol 2009; 47: 1143-8.
44. Gherardi G, Imperi M, Baldassarri L et al. Molecular epidemiology and distribution of serotypes, surface proteins and antibiotic resistance among group B streptococci in Italy. J Clin Microbiol 2007; 45: 2009-16.
45. Danesh S, Hensler ME, Van Sorge NM et al. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob Agents Chemother 2008; 52: 2915-8.
46. Kimura K, Suzuki S, Wachino J-I et al. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 2008; 52: 2890-7.
47. Culebras E, Rodriguez-Avial I, Betriu C et al. Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae. Antimicrob Agents Chemother 2002; 46: 1574-6.
48. Domelier AS, van der Mee-Marquet N, Arnault L et al. Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains. J Antimicrob Chemother 2008; 62: 1227-33.
49. von Both U, Buerckstuemmer A, Fluegge K et al. Heterogeneity of genotype-phenotype correlation among macrolide-resistant Streptococcus agalactiae isolates. Antimicrob Agents Chemother 2005; 49: 3080-2.
50. Al-Lahham A, Appelbaum PC, van der Linden M et al. Telithromycin-nonsusceptible clinical isolates of Streptococcus pneumoniae from Europe. Antimicrob Agents Chemother 2006; 50: 3897-900.
51. Poyart C, Jardy L, Quesne G et al. Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother 2003; 47: 794-7.
52. Gevers D, Danielsen M, Huys G et al. Molecular characterization of tet(M) genes in Lactobacillus isolates from different types of fermented dry sausage. Applied Env Microbiol 2003; 69: 1270-5.
53. Oggioni MR, Dowson CG, Maynard Smith J et al. The resistance gene tet(M) exhibits mosaic structure. Plasmid 1996; 35: 156-63.
54. Poupolo KM, Klinzing DC, Lin MP et al. A composite transposon associated with erythromycin and clindamycin resistance in group B Streptococcus. J Med Microbiol 2007; 65: 947-55.
55. Rice LB. Tn916 family conjugative transposons and dissemination of antimicrobial resistance determinants. Antimicrob Agents Chemother 1998; 42: 1871-7.
56. Feld L, Bielak E, Hammer K et al. Characterization of a small erythromycin resistance plasmid pLFE1 from food-isolate Lactobacillus plantarum M345. Plasmid 2009; 61: 159-70.
57. Lacks SA, Lopez P, Greenberg B et al. Identification and analysis of genes for tetracycline resistance and replication functions in the broad-host-range plasmid pLS1. J Mol Biol 1986; 192: 753-65.
58. Woodbury RL, Klammer KA, Xiong Y et al. Plasmid-borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains. Antimicrob Agents Chemother 2008; 52: 1140-3.